The CORI is the product for the direct reduction unit:
First, it will be stored in product passivation silos, its transportation by conveyors. After that, it will be stored in the warehouse for further use.
Production rate fo312 T/H. Assuming 8,000 hours of annual
operation, this equates to in annual production of 2,500,000 tonnes.
-IRON: (Rod a Benton):Hot-rolled product in multipurpose steel for high-adherence construction, weldable in RB 500 grade. NA 8634(2015) and ISO 6935-2 (2015). Diameter:
A wide range of diameters: 8,10,12, 14, 16,20,25,32,40 mm.
Length :12m (-0mm +100mm) with the possibility of making specific lengths of less than 12m according to customer demand for diameters ranging from 8mm to 16mm.
12m to 18m for diameters ranging from 16mm to 40mm.
Marking :
A specific AQS marking is engraved on the rebar bars for the diameters: 8,10,12,14,16mm And the identifying code AQS-diameter-RB500 for the diameters: 16,20,25,32,40mm
- Portland Cement 42.5 (Bags, Bulk)
-Wire rod: of round section with a diameter varying between 5.5 mm to 14 mm, of high quality.
The round and smooth wire rod is obtained by hot rolling in accordance with the Algerian standard an 8634 and according to international standards.-The Fields Of Use Of Wire Rod Are As Follows:- Drawn Wire-Welded Mesh-Nail, Tie Wire, Galvanized Wire- Gabions- Barbed Wire-Spring Wire- Bolt-Nut-Screw- Paperclips-Pickup Wire-Welding Wire
-BILLET: A billet is a section of metal used to roll into bars and shapes. It can be produced with ingots or directly by continuous casting. Billets are used as raw materials or for extrusion, forging, rolling and other metal processing operations.
Made in Canada
Health Canada approved
CE Mark and ISO certified
The product has proven to have 100% Specificity and 96% Sensitivety
Stock availabity: 2 Million tests/kit in Canada
Production: up to 5 Million tests/kit weekly
The Rapid Response COVID-19 Antigen Rapid Test Device is an in vitro immunochromatographic assay for the direct and qualitative detection of SARS-CoV-2 viral nucleoprotein antigens from nasal and nasopharyngeal secretions from individuals suspected of COVID-19 within 6 days of symptom onset. This test is authorized for use at the Point of Care i.e., in patient care setting. Results are for the identification of SARS-CoV-2 viral nucleoprotein antigen. Antigen is generally detectable in nasopharyngeal and nasal secretions during the acute phase of infection. Positive results indicate the presence of viral antigens, but clinical correlation with patient history and other diagnostic information is necessary to determine infection status. Positive results do not rule out bacterial infection or co-infection with other viruses. The agent detected may not be the definite cause of disease. Laboratories are required to report all positive results to the appropriate public health authorities. Negative results should be treated as presumptive, and do not rule out SARS-CoV-2 infection and should not be used as the sole basis for treatment or patient management decisions, including infection control decisions. Negative results should be considered in the context of a patientâ??s recent exposures, history, and the presence of clinical signs and symptoms consistent with COVID-19, and confirmed with a molecular assay, if necessary, for patient management. The Rapid Responseâ?¢ COVID-19 Antigen Rapid Test Device is for use at the Point of Care for professional use only.
PRODUCT INFORMATION:
Product: Rapid Respose
Sample: Nasal / Nasopharyngeal secretions
Format: Cassette
Quantity: 25 Tests/Kit per box
Time to result: 15 minutes
Storage Condition: 2-30 C/36-86 F
Test Principle: Immunochromatographic Assay
CONTENTS - Individually packed test devices
Extraction Buffer
Extraction tube
Nozzle with filter
Tube stand
Individually packed swabs
Package Insert
